Home LiteratureArticle Details
PMID: 3308708 Published · ppublish English Journal Article

Fate of Legionella pneumophila Philadelphia-1 strain in resident, elicited, activated, and immune peritoneal macrophages of guinea pigs.

Infection and immunity ·Vol. 55 ·No. 10 ·1987-10-00 ·Pages 2477-82

Yoshida S, Mizuguchi Y, Nikaido Y, Mitsuyama M, Nomoto K

Abstract

Legionella pneumophila is known to grow intracellularly in resident peritoneal macrophages of guinea pigs. The present study was done to determine what kinds of macrophage stimulants are able to activate guinea pig macrophages to inhibit intracellular growth of the organism. Peritoneal macrophages were harvested from healthy guinea pigs, from guinea pigs injected intraperitoneally with proteose peptone (PP) or thioglycolate medium, from guinea pigs injected intraperitoneally with live Mycobacterium bovis BCG or killed Propionibacterium acnes (Corynebacterium parvum), and from guinea pigs surviving infection with live L. pneumophila. After in vitro phagocytosis, the L. pneumophila CFU in each well were counted on charcoal-yeast extract agar plates. In the macrophages elicited by PP or thioglycolate medium, the organism grew as well as it did in resident macrophages. In BCG-activated and immune macrophages, growth was inhibited almost completely. In P. acnes-activated macrophages, the initial growth of L. pneumophila was inhibited to some extent, but its growth reached the same level as in the resident and PP-induced macrophages after 3 or 4 days of culture. In the lethal challenge experiments in vivo, the superior protection provided by BCG over P. acnes was ascertained and the importance of macrophages in resistance to L. pneumophila was confirmed. Difference of activation by BCG and P. acnes in relation to the inhibition of intracellular growth of L. pneumophila in guinea pig macrophages is discussed.

MeSH Terms
Animals Cells, Cultured Female Glucose/metabolism Guinea Pigs Immunization Legionella/growth & development,immunology Macrophage Activation Macrophages/immunology,microbiology Mycobacterium bovis/immunology Phagocytosis Propionibacterium acnes/immunology
Chemicals
Glucose
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Yoshida S
Department of Microbiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Mizuguchi Y
Nikaido Y
Mitsuyama M
Nomoto K
References (31)
31 references, click to expand
  1. Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille calmette-guérin.
    J Infect Dis. 1977 May;135(5):763-70 PMID: 192811
  2. Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice.
    Infect Immun. 1975 Dec;12(6):1325-30 PMID: 1107224
  3. In vitro killing of schistosomula of Schistosoma mansoni by BCG and C. parvum-activated macrophages.
    J Immunol. 1979 May;122(5):1655-7 PMID: 376723
  4. Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila.
    J Clin Microbiol. 1979 Oct;10(4):437-41 PMID: 393713
  5. Relation between bactericidal and phagocytic activities of peritoneal macrophages induced by irritants.
    J Reticuloendothel Soc. 1980 Apr;27(4):421-7 PMID: 6768886
  6. Identification of a cytotoxin produced by Legionella pneumophila.
    Infect Immun. 1980 Jul;29(1):271-4 PMID: 6995339
  7. Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.
    J Clin Invest. 1980 Sep;66(3):441-50 PMID: 7190579
  8. Characteristics of resistance to Listeria monocytogenes enhanced by Corynebacterium parvum in mice.
    Immunology. 1980 May;40(1):33-9 PMID: 6968291
  9. In vitro responses of guinea pig peritoneal macrophages to Legionella pneumophila.
    Infect Immun. 1981 Mar;31(3):1209-13 PMID: 7228402
  10. Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.
    J Exp Med. 1981 Nov 1;154(5):1618-35 PMID: 7299350
  11. The effects of Legionella pneumophila toxin on oxidative processes and bacterial killing of human polymorphonuclear leukocytes.
    J Infect Dis. 1982 Sep;146(3):328-34 PMID: 7050255
  12. Susceptibility of Legionella pneumophila to oxygen-dependent microbicidal systems.
    J Immunol. 1982 Nov;129(5):2192-7 PMID: 6288801
  13. Peptidoglycan of Legionella pneumophila: apparent resistance to lysozyme hydrolysis correlates with a high degree of peptide cross-linking.
    J Bacteriol. 1983 Jan;153(1):520-6 PMID: 6129241
  14. Effect of oxygen-dependent antimicrobial systems on Legionella pneumophila.
    Infect Immun. 1983 Jan;39(1):487-9 PMID: 6295960
  15. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
    J Exp Med. 1983 Sep 1;158(3):670-89 PMID: 6411853
  16. Partial characterization of peptidoglycan-associated proteins of Legionella pneumophila.
    J Biochem. 1983 Aug;94(2):601-6 PMID: 6630177
  17. The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes.
    J Exp Med. 1983 Dec 1;158(6):2108-26 PMID: 6644240
  18. Antibiotic susceptibility of Legionella pneumophia Philadelphia-1 in cultured guinea-pig peritoneal macrophages.
    J Gen Microbiol. 1984 Apr;130(4):901-6 PMID: 6736922
  19. Activation of human macrophages. Comparison of other cytokines with interferon-gamma.
    J Exp Med. 1984 Aug 1;160(2):600-5 PMID: 6206183
  20. Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon.
    Eur J Immunol. 1984 Oct;14(10):964-7 PMID: 6436036
  21. Legionella pneumophila inhibits acidification of its phagosome in human monocytes.
    J Cell Biol. 1984 Dec;99(6):1936-43 PMID: 6501409
  22. Different mechanisms of macrophage activation with guinea pig macrophage activation factor, lipopolysaccharide and muramyl dipeptide.
    Int Arch Allergy Appl Immunol. 1985;76(4):296-301 PMID: 3884516
  23. Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.
    Proc Natl Acad Sci U S A. 1985 Nov;82(21):7404-8 PMID: 3933006
  24. Lack of biological significance of in vitro Brugia malayi microfilarial cytotoxicity mediated by Propionibacterium acnes ("Corynebacterium parvum")-and Mycobacterium bovis BCG-activated macrophages.
    Infect Immun. 1986 May;52(2):534-7 PMID: 3516877
  25. Multiplication of Legionella pneumophila Philadelphia-1 in cultured peritoneal macrophages and its correlation to susceptibility of animals.
    Can J Microbiol. 1986 May;32(5):438-42 PMID: 3719461
  26. Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila.
    J Immunol. 1986 Oct 15;137(8):2662-9 PMID: 3093580
  27. Effect of Corynebacterium parvum treatment on the growth of Salmonella enteritidis in mice.
    Infect Immun. 1974 May;9(5):863-9 PMID: 4596278
  28. The influence of immunologically committed lymphoid cells on macrophage activity in vivo.
    J Exp Med. 1969 May 1;129(5):973-92 PMID: 4976110
  29. THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.
    J Exp Med. 1964 Jul 1;120:105-20 PMID: 14194388
  30. Effect of Corynebacterium parvum on the course of a Listeria monocytogenes infection in normal and congenitally athymic (nude) mice.
    Zentralbl Bakteriol Orig A. 1975;231(1-3):197-205 PMID: 808049
  31. Lack of responsiveness of C3H/HeJ macrophages to lipopolysaccharide: the cellular basis of LPS-stimulated metabolism.
    J Immunol. 1979 Mar;122(3):932-5 PMID: 376709
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1987-10-00
Pages
2477-82
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC260733
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]